147 related articles for article (PubMed ID: 10431585)
1. [A case of breast cancer with liver metastases responding remarkably to combination therapy of mitoxantrone (MIT), doxifluridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Fujitake S; Maeda Y; Shimizu M; Nozaki H; Tohyama M; Kataoka S
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1177-80. PubMed ID: 10431585
[TBL] [Abstract][Full Text] [Related]
2. [A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Kobayashi J; Kubota K; Ishikawa H; Asaumi S; Iwanami K; Matsumoto H; Kawashima K; Yokoe T; Iino Y; Morishita Y
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2513-6. PubMed ID: 7944501
[TBL] [Abstract][Full Text] [Related]
3. [A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
Maruyama S; Okumoto T; Kawasaki K; Ino H; Kanaya Y; Otani J; Yokoyama N; Soda M
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2235-8. PubMed ID: 11142168
[TBL] [Abstract][Full Text] [Related]
4. [A case of giant advanced breast cancer responding remarkably to chemo-endocrine therapy chiefly with doxifluridine].
Fujitake S; Maeda Y; Shimizu M; Nozaki H; Tohyama M; Kataoka S
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2283-6. PubMed ID: 9881086
[TBL] [Abstract][Full Text] [Related]
5. A combination chemoendocrine therapy of mitoxantrone, doxifluridine, and medroxyprogesterone acetate for anthracycline-resistant advanced breast cancer.
Iino Y; Yokoe T; Sugamata N; Maemura M; Takei H; Horiguchi J; Takeyoshi I; Ohwada S; Morishita Y; Kusaba T; Ishida T; Yokomori T; Fujii T; Endo K; Shiozaki H; Aiba S; Takano A; Kishi S
Cancer Chemother Pharmacol; 1998; 41(3):243-7. PubMed ID: 9443642
[TBL] [Abstract][Full Text] [Related]
6. [A case of recurrent breast cancer with multiple liver metastases responding to combination therapy of capecitabine and MPA].
Konishi K; Hasegawa N; Kawabata M; Abeshima S; Ichimura T; Kaneko H; Nakayama T
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1689-91. PubMed ID: 17940392
[TBL] [Abstract][Full Text] [Related]
7. [Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report].
Hoshino K; Nakamura M; Ikeda H; Koyama T; Morishita Y
Gan To Kagaku Ryoho; 1999 Jun; 26(7):983-7. PubMed ID: 10396328
[TBL] [Abstract][Full Text] [Related]
8. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
Izumi M; Iino Y; Yokoe T; Inoue T; Yamada T; Kobayashi I; Andoh T; Yokota T; Iijima T; Morishita Y
Gan To Kagaku Ryoho; 1994 Feb; 21(2):265-8. PubMed ID: 8311500
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of mitoxantrone, doxifluridine and medroxyprogesterone acetate as second-line treatment for anthracycline-resistant metastatic breast cancer.
Yokoe T; Iino Y; Sugamata N; Aoyagi H; Takai Y; Takei H; Maemura M; Ohwada S; Morishita Y
Anticancer Res; 1995; 15(5B):2303-5. PubMed ID: 8572643
[TBL] [Abstract][Full Text] [Related]
10. [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):973-7. PubMed ID: 11478147
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer].
Matsuoka T; Nomizu T; Yabuta T; Katagata N; Watanabe F; Yamaki Y; Tsuchiya A; Takenoshita S
Gan To Kagaku Ryoho; 2000 Jul; 27(7):1051-5. PubMed ID: 10925694
[TBL] [Abstract][Full Text] [Related]
12. [A case of breast cancer with multiple bone metastases that responded remarkably to doxifluridine (5'-DFUR), cyclophosphamide (CPA), medroxyprogesterone acetate (MPA) and pamidronate disodium therapy].
Kusama M; Kaise H; Nakayama S; Ota D; Aoki T; Koyanagi Y; Misaka T; Matunaga T
Gan To Kagaku Ryoho; 2002 May; 29(5):785-9. PubMed ID: 12040686
[TBL] [Abstract][Full Text] [Related]
13. [5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
Yoshinaka K; Yagi M; Ohtagaki S; Toi M; Toge T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):115-8. PubMed ID: 1824814
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
[TBL] [Abstract][Full Text] [Related]
15. [Intra-arterial infusion chemotherapy for liver metastases from breast cancer].
Masuda N; Yayoi E; Furukawa J; Maruhashi S; Tokunaga M; Takiguchi S; Matsui S; Yano H; Tateishi H; Kinuta M; Maruyama H; Ooi H; Okamura J
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1537-41. PubMed ID: 8854800
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate.
Zaucha R; Sosińska-Mielcarek K; Jassem J
Breast; 2004 Aug; 13(4):321-4. PubMed ID: 15325667
[TBL] [Abstract][Full Text] [Related]
17. [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
Satoh Y; Une Y; Fujisawa J; Uchino J
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2509-12. PubMed ID: 7944500
[TBL] [Abstract][Full Text] [Related]
18. [A case of intra-arterial infusion chemotherapy for liver metastases of breast cancer].
Yasui M; Yayoi E; Nishi T; Yamasaki M; Kishibuchi M; Yagyu T; Kawasaki K
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1963-6. PubMed ID: 10560437
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
Gan To Kagaku Ryoho; 1992 Jan; 19(1):107-10. PubMed ID: 1530905
[TBL] [Abstract][Full Text] [Related]
20. 5'-deoxy-5-fluorouridine, medroxyprogestrone acetate and mitoxantrone hydrochloride for advanced or recurrent breast cancer.
Sato K; Hiraide H; Tamakuma S; Tabei T; Maruyama M; Touma M; Okamura H; Matsumoto F; Akao S; Ishikawa H; Yagi Y; Mochizuki H
Breast Cancer; 2001; 8(1):58-62. PubMed ID: 11180767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
